CXCR4 and breast carcinoma: CXCR4 is one of the chemokine receptors that are critical for chemotherapy of metastatic cells, and treatment of MDA-MB-231 breast cancer cells with DHA reduced the surface expression of CXCR4 and reduced CXCR4-mediated cell migration.